AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

TherapeuticsMD, Inc. Director's Dealing 2013

May 16, 2013

35134_dirs_2013-05-16_b2ffaf24-48aa-4b07-8caa-e61b67289603.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2013-05-16

Reporting Person: MUSING JULES A. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Sotck	10800	Direct